-
COMy 2026 | Professor Kenneth Anderson: Multiple Myeloma Moves Closer to Clinical Cure
At this year’s congress, Professor Kenneth Anderson, Director of the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute and Harvard Medical School, delivered a landmark keynote presentation on the…
-
COMy 2026 | Professor Nizar Bahlis: A Comprehensive Framework for Understanding and Overcoming Bispecific Antibody Resistance in Multiple Myeloma
From May 13–19, 2026, the 12th World Congress on Multiple Myeloma (COMy 2026) was held in Paris, France. As one of the most influential global meetings in the field of multiple myeloma (MM), the congress brought together leading investigators to discuss the latest advances in translational research, innovative therapies, and patient care.
-
COMy 2026 | Professor Philippe Moreau: Thirty-Five Years of Progress—Tracing the Evolution of Frontline Therapy for Transplant-Eligible Multiple Myeloma
From May 13–19, 2026, the 12th World Congress on Multiple Myeloma (COMy 2026) was held in Paris, France. As one of the most influential meetings in the field of multiple myeloma (MM), the congress brought together leading experts to discuss the latest advances in research, innovative therapies, and patient care.
-
COMy 2026 | Professor Salomon Manier: Survival Breakthroughs and a New Era of Personalized Treatment for Transplant-Ineligible Multiple Myeloma
From May 13–19, 2026, the 12th World Congress on Multiple Myeloma (COMy 2026) was held in Paris, France. As one of the most influential international meetings in the field of multiple myeloma (MM), the congress brought together leading experts from around the world to discuss the latest advances in research, novel therapies, and patient care.
-
COMy 2026 | Professor Shaji Kumar: An Early Look at the Landmark Changes in the New Multiple Myeloma Response Criteria
From May 13–19, 2026, the 12th World Congress on Multiple Myeloma (COMy 2026) was held in Paris, France. As one of the most influential global meetings in the field of multiple myeloma (MM), the congress brought together leading experts to discuss the latest advances in translational research, novel therapeutics, and patient care.
-
COMy 2026 | Professor Steven P. Treon: The Precision Era of Waldenström Macroglobulinemia—Overcoming Resistance and Exploring New Therapeutic Targets
From May 13–19, 2026, the 12th World Congress on Multiple Myeloma (COMy 2026) was held in Paris, France. As one of the most influential international meetings in the field of multiple myeloma and related plasma cell disorders, the congress brought together leading experts worldwide to discuss the latest advances in translational research, novel therapeutics, and…
-
COMy 2026 | Honoring the Architects of Progress: Major Awards Spotlight the Past, Present, and Future of Multiple Myeloma Research
From May 14–17, 2026, the 12th International Congress on Controversies in Multiple Myeloma (COMy 2026) was successfully held in Paris, France. Recognized as one of the most influential academic meetings in the field of multiple myeloma (MM), COMy has long been distinguished by its focused format, in-depth scientific discussions, and emphasis on unresolved clinical questions.
-
Learning from History: Dr. Ludovico Docimo on the Rise of Robotic Surgery in Colorectal ORs
From May 15 to 17, 2026, the Academic Seminar on Clinical Practices of Colorectal Surgery was held in Hangzhou. Dr. Ludovico Docimo, Professore Ordinario e Primario of the UOC of General, Minimally Invasive and Obesity Surgery at the University of Campania “Luigi Vanvitelli” (Italy), shared his view that robotic surgery will transform colorectal operating rooms,…
Connecting Medical Expertise through Media